基因工程对现代医学技术的促进作用
摘要
关键词
全文:
PDF参考
[1] Selivanova OM, Grishin SY, Glyakina AV, Sadgyan AS, Usha- kova NI, Galzitskaya OV. Analysis of Insulin Analogs and the Strategy of Their Further Development. Biochemistry (Mosc). 2018;83(Suppl 1):S146-S162. doi:10.1134/S0006297918140122.
[2] Johnson, I. S. (1983) Human insulin from recombinant DNA technology, Science, 219, 632-637.
[3] 人体“基因剪刀”抗癌临床试验首次在美国通过审查.人 民网 .
[4] Khan FA, Pandupuspitasari NS, Chun-Jie H, et al. CRISPR/ Cas9 therapeutics: a cure for cancer and other genetic diseases. Oncotarget. 2016 Aug;7(32):52541-52552. DOI: 10.18632/onco- target.9646.
[5] Thakore PI, D’Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA. Highly spe- cific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nature methods. 2015;12:1143–49.
[6] 石琼,孙颖主编;游欣欣,白洁副主编 . 海洋生物基因组 学概论 =Introduction to marine genomics[M]. 中山大学出版 社 ,2015.08.
[7] Morena J, Gupta A, Hoyle JC. Charcot-Marie-Tooth: From Mole- cules to Therapy.Int J Mol Sci. 2019;20(14):3419. Published 2019 Jul 12. doi:10.3390/ijms20143419.
[8] Cohn, L.; Delamarre, L. Dendritic cell-targeted vaccines. Front. Immunol.2014,5, 255.
[9] Lundstrom K. RNA Viruses as Tools in Gene Therapy and Vac- cine Development. Genes (Basel). 2019;10(3):189. Published 2019 Mar 1. doi:10.3390/genes10030189.
DOI: http://dx.doi.org/10.18686/xyfyx.v2i10.37174
Refbacks
- 当前没有refback。